Mannkind (MNKD) Cash from Financing Activities (2010 - 2026)

Mannkind's (MNKD) quarterly Cash from Financing Activities came in at -$35.4 million in Q1 2026, down 2647.19% year-on-year from $1.4 million in Q1 2025, and down 114.31% on a QoQ basis from $247.4 million in Q4 2025.

Mannkind (MNKD) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Mannkind (MNKD) has 17 years of Cash from Financing Activities data on file, last reported at -$35.4 million in Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 2647.19% year-over-year to -$35.4 million in Q1 2026; TTM through Mar 2026 was $278.3 million, a 310.2% increase from a year earlier, with the FY2025 full-year figure at $315.1 million, up 329.55% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at -$35.4 million, down from $247.4 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for MNKD reached as high as $247.4 million in Q4 2025 and fell as low as -$86.9 million in Q4 2024.
  • Historically, Cash from Financing Activities has averaged $17.7 million across 5 years, with a median of -$283000.0 in 2023.
  • Across the five-year window, Cash from Financing Activities surged 4915.26% in 2023 and slumped 2647.19% in 2026, its largest moves.
  • Year by year, Cash from Financing Activities stood at $2.8 million in 2022, then jumped by 4915.26% to $141.7 million in 2023, then sank by 161.33% to -$86.9 million in 2024, then soared by 384.71% to $247.4 million in 2025, then sank by 114.31% to -$35.4 million in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were -$35.4 million in Q1 2026, $247.4 million in Q4 2025, and $71.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Mannkind 1.20 Bn 1.07 Bn 82.66 Mn -35.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -35.41 Mn
Mar 31, 2026 -35.41 Mn
Dec 31, 2025 247.41 Mn
Dec 31, 2025 247.41 Mn
Sep 30, 2025 71.81 Mn
Sep 30, 2025 71.81 Mn
Jun 30, 2025 -5.51 Mn
Jun 30, 2025 -5.51 Mn
Mar 31, 2025 1.39 Mn
Mar 31, 2025 1.39 Mn
Dec 31, 2024 -86.90 Mn
Dec 31, 2024 -86.90 Mn
Sep 30, 2024 -2.34 Mn
Sep 30, 2024 -2.34 Mn
Jun 30, 2024 -44.55 Mn
Jun 30, 2024 -44.55 Mn
Mar 31, 2024 -3.47 Mn
Mar 31, 2024 -3.47 Mn
Dec 31, 2023 141.68 Mn
Dec 31, 2023 141.68 Mn